|Day Low/High||8.63 / 8.71|
|52 Wk Low/High||6.64 / 12.83|
Presentation of Application Techniques and Therapeutic Approaches Using MiMedx EpiFix and AmnioFix for Wound Healing and Surgical Procedures
PRESENTERS OVERWHELMINGLY ASK FDA TO WITHDRAW OR SIGNIFICANTLY MODIFY DRAFT GUIDANCE
Study quantifies in MiMedx dHACM allografts numerous matrix components, growth factors, proteases and protease inhibitors known to play a role in wound healing
AMNIOFILL™ IS THE FIRST PRODUCT IN THE MIMEDX PLACENTAL COLLAGEN MATRIX FAMILY TO BE COMMERCIALLY INTRODUCED
FDA AGREES TO SHORTEN IMMUNOGENIC TESTING BY ONE YEAR IN THE COMPANY'S PLANTAR FASCIITIS STUDY
Trade-Ideas LLC identified MiMedx Group (MDXG) as a weak on high relative volume candidate
New Lyophilized OrthoFlo version is an advancement in product logistics and safety
$57.3 MILLION Q2 2016 REVENUE IS 26% INCREASE OVER Q2 2015
In trading on Friday, shares of MiMedx Group Inc crossed above their 200 day moving average of $8.34, changing hands as high as $8.38 per share. MiMedx Group Inc shares are currently trading up about 2.7% on the day.
Case series determines wounds with exposed bone or tendon treated with dHACM and STSG is viable low-cost treatment alternative to the gold standard for limb salvage
The wound care provider filed the suit for allegedly falsifying and misleading consumers with clinical data.
Company Reiterates Second Quarter Guidance
Trade-Ideas LLC identified MiMedx Group (MDXG) as a strong on high relative volume candidate
The most recent short interest data was recently released for the 03/31/2016 settlement date, and MiMedx Group Inc is one of the most shorted stocks of the Russell 3000, based on 19.83 "days to cover" versus the median component at 6.16. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
Review is flawed with unmatched, uncontrolled and subjective variables